Skip to content
Care, coaching and clear next steps.
I start here!
Menu
← All articles

Evidence and approval

FDA-Approved Peptides: Medicine List and How to Check

Compare six FDA-approved peptide medicines, their uses and approval years. Learn how to verify a product and why research peptides are different.

Educational content. Clinical review pending. How we prepare our guides

Yes—some peptide medicines are FDA-approved, including specific products containing semaglutide, tirzepatide, liraglutide and tesamorelin. Approval applies to a named product, formulation and labeled uses. It does not extend to every preparation containing the same ingredient, or to everything sold as a “peptide.”

Approval and evidence answer different questions. A study can investigate an unapproved product. An approved medicine has specific uses and prescribing information; that does not establish every claim someone might make about its ingredient.

List of FDA-approved peptide medicines

These six examples cover four molecules discussed in Pephelp’s guide. This is a selected list, not every approved peptide medicine. The product records and linked labels below were checked November 11, 2026.

Product and molecule Selected approved use First approval of this product FDA record
Wegovy injection · semaglutide Weight management for eligible patients; other indications are in the current label 2021 NDA 215256
Ozempic injection · semaglutide Type 2 diabetes; additional cardiovascular and kidney indications for specified patients 2017 NDA 209637
Zepbound injection · tirzepatide Weight management; moderate-to-severe obstructive sleep apnea in adults with obesity 2023 NDA 217806
Mounjaro injection · tirzepatide Type 2 diabetes in patients meeting the current label criteria 2022 NDA 215866
Saxenda injection · liraglutide Weight management for eligible patients 2014 NDA 206321
Egrifta WR injection · tesamorelin Excess abdominal fat in adults with HIV-associated lipodystrophy; not general weight-loss management 2025 for WR FDA product list, BLA 022505 product 003

Approval belongs to the named product, formulation and labeled uses. It does not cover every compounded preparation or online vial with the same ingredient name. These years identify the listed product, not every later indication or the molecule’s earliest approval. For example, tesamorelin’s initial US approval was in 2010, while Egrifta WR is a later formulation.

Read the current labels for Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda and Egrifta WR for full indications, eligibility and safety information. A place in this table does not mean Pephelp offers that medicine or that it suits you.

Check the actual product in FDA records

FDA’s Drugs@FDA database provides approval information and associated documents. FDA explains its scope in About Drugs@FDA.

How do I check whether an offered weight-loss medication is FDA-approved?

Use the offer and the FDA record side by side:

Check What must match
Product identity Full product name, active ingredient and named manufacturer or applicant
Presentation Dosage form, strength and route: for example, an injection and a tablet are different presentations
Approval record The product entry, approval history and associated prescribing information
Intended use The label’s indications, eligibility and safety information, discussed with your prescriber

Worked example: an offer says only “semaglutide.” Ask for the exact product name and presentation. Search that name in Drugs@FDA, then compare the offer with the corresponding record and label. Finding an approved product containing semaglutide does not establish that a different preparation is approved.

If the offer is compounded semaglutide, a Wegovy or Ozempic approval record does not cover it. Compounded drugs are not FDA-approved. FDA’s compounding explanation.

Ask the prescriber or pharmacist: “Which exact product will I receive, and can you show me the matching record or explain its compounded status?” This checking method and the linked FDA guidance were rechecked October 21, 2026.

A pharmacy listing or an ingredient name is not a substitute for a matching approval record. If you cannot reconcile the documents, ask the prescriber or pharmacist to explain the discrepancy before drawing a conclusion.

Words that can be confused with approval

Registered and listed are not synonyms for FDA-approved. FDA explains that its oversight differs between product categories and that facility registration does not itself mean a product is approved. Supplements and most cosmetics do not undergo drug-style premarket approval. FDA consumer explanation.

“Clinical trials,” “research use” and a committee discussion also describe different things from a marketing approval. In the field guide, research type is deliberately kept in a separate column from US status. A trial can have a negative result; its existence does not establish that treatment helps.

Approval is not personal suitability

Reading a label is a starting point for a discussion. It is not a way to choose your own prescription. The fact that one product is approved for one condition does not show that a different formulation is appropriate for another goal.

Use the list of peptides and what the evidence shows to compare selected compounds and follow their sources. If your question concerns a compounded product, read how compounded semaglutide differs from Ozempic. For an appointment, bring the exact product name and the claim you want to understand, rather than asking only whether “peptides” are approved.

If weight management is your starting question, use our weight-loss options guide. If an offer promises the effect of a prescription medicine through a different route, our GLP-1 patch evidence check shows how to examine the claim.

What support belongs alongside weight-management treatment?

Product verification is only the first question. Ask who reviews symptoms, helps with nutrition and activity, and coordinates follow-up. Our GLP-1 meals guide and muscle and strength guide offer questions to bring to that discussion. Pephelp’s GLP-1 coaching supports agreed routines for people with Pephelp or an outside prescriber; it does not replace prescribing or clinical assessment.

Common approval questions

Are there FDA-approved peptides for weight loss?

Yes. Wegovy, Zepbound and Saxenda have weight-management indications for eligible patients. That does not make every GLP-1 brand a weight-management product or establish individual suitability. Compare the exact product and current label with your prescriber; the table above is a starting point.

Is BPC-157 FDA-approved?

No FDA-approved BPC-157 drug was identified in the sources checked for this guide. FDA’s assessment of BPC-157 for proposed compounding uses is not a marketing approval. A policy discussion, a pharmacy’s ability to compound and approval of a finished medicine are different questions. See the BPC-157 evidence and sources and FDA’s assessment.

Where is the FDA list of approved peptide drugs?

Use Drugs@FDA to search by the exact medicine or ingredient, then open its approval history and label. Some biologic products are also recorded in FDA’s Purple Book. A vendor’s peptide list or an ingredient listing does not replace those records.

Sources and further reading

  1. FDA: Drugs@FDA approval records (opens in a new tab)
  2. FDA: CDER biologic product list, Egrifta WR approval (opens in a new tab)
  3. Ozempic prescribing information (opens in a new tab)
  4. Mounjaro prescribing information (opens in a new tab)
  5. FDA: Understanding the risks of compounded drugs (opens in a new tab)
  6. FDA: About Drugs@FDA (opens in a new tab)
  7. FDA: Is It Really FDA Approved? (opens in a new tab)
  8. Wegovy prescribing information (opens in a new tab)
  9. Zepbound prescribing information (opens in a new tab)
  10. Saxenda prescribing information (opens in a new tab)
  11. Egrifta WR prescribing information (opens in a new tab)

Source review October 21, 2026. Individual checks may be dated in the article. Prices, labels and policies can change. Linked studies being peer reviewed does not mean this article has been clinically reviewed.

Your next step with Pephelp

Your weight-loss goal. Your kind of support.

Tell us about your goals, then explore medical care with optional coaching for food, strength and everyday habits.

Start my weight-loss quiz

US care · Clinical review before treatment

Compare plans and prices